WAM
AGTC

Warberg Asset Management’s Applied Genetic Technologies Corporation AGTC Stock Holding History

Warberg Asset Management’s Portfolio AGTC Stock Details AGTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-30,000
Closed -$8K – 341
2022
Q3 		$8K Buy
+30,000
New +$13.1K ﹤0.01% 246

Warberg Asset Management's AGTC Position: Q4 2022 in Review

Warberg Asset Management sold out of Applied Genetic Technologies Corporation (AGTC) in Q4 2022, closing a stake of 30,000 shares — an estimated $8K sold.

Warberg Asset Management first reported a position in AGTC in Q3 2022 and held it in 1 quarter. The position peaked at $8K in Q3 2022. 0 funds tracked by Wall St. Rank hold AGTC as of Q4 2022.

  • Warberg Asset Management reported no remaining Applied Genetic Technologies Corporation position as of Q4 2022 after selling out during the quarter.
  • Warberg Asset Management sold 30,000 Applied Genetic Technologies Corporation shares in Q4 2022, an estimated $8K.
  • Warberg Asset Management first reported a position in Applied Genetic Technologies Corporation in Q3 2022 and held it in 1 quarter.
  • Warberg Asset Management's Applied Genetic Technologies Corporation position peaked at $8K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Applied Genetic Technologies Corporation as of Q4 2022.

Based on Warberg Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.